Before 2011, when HIV infections among people who injected drugs in Athens, Greece rose suddenly and steeply, the epidemic of the virus in that country was classified as a low-level one; affecting less than 1 percent of the general population, and less than 5 percent of any of the populations at greatest risk. In the […]
The HIV community lost a leader and a champion with the death of Dr. Mark Wainberg Tuesday. The chair of the HIV Medicine Association, a producer of this blog, released a statement recognizing some of Dr. Wainberg’s contributions today, which we share here: The HIV community is deeply saddened to learn of the tragic loss […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]